Four time Olympian joins Mount Magnet South as technical advisor
Mount Magnet South (ASX:MUM), soon to be renamed Impression Healthcare, yesterday added another high profile sports identity to its administration.
Four time Olympian, David Neesham has joined the MMS team as a technical advisor.
Neesham represented Australia four times in Waterpolo career spanning 13 years, but also has vast experience in the field of dentistry.
As MMS, through its Gameday International business, sets out to bring high quality, custom-made, affordable mouthguards to sports clubs across Australia market, it continues to add expertise and sporting nous to its management team.
Neesham is not only an Olympic athlete, he is also a respected Perth dentist, healthcare executive and educator.
His career spans 40 years and includes roles as Principal of Health Services WA’s Dental Therapy Training School and as Director of Dental Services for WA – a role he held for 17 years. IN terms of sports administration, Neesham has served as Chairman of the West Australian Sports Council and has been a Member of the Australian Institute of Sport Advisory Committee.
He is currently on the Board of the Clontarf Foundation, which exists to improve the education, discipline, life skills, esteem and employment opportunities of young Aboriginal men.
“We are delighted to have secured the services of David Neesham,” said Chairman Alex Pismiris.
“His substantial expertise and experience in both dental and sports fields will be highly beneficial to the commercial development of Impression Healthcare and the initial Gameday mouthguard product line. David’s extensive network in the dental industry and the Australian sporting world further complement the reach and access of our highly regarded Management Team including John Worsfold and Matt Weston.”
The appointment of Neesham comes quickly after MMS onboarded NRL favourite Matt Ballin as a Gameday ambassador.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.